Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B

Mura, Pasquale, Camalli, Mercedes, Casini, Angela ORCID: https://orcid.org/0000-0003-1599-9542, Gabbiani, Chiara and Messori, Luigi 2010. Trans-cis-cis-[RuCl2(DMSO)2(2-amino-5-methyl-thiazole)2], (PMRu52), a novel ruthenium(II) compound acting as a strong inhibitor of cathepsin B. Journal of Inorganic Chemistry 104 (2) , pp. 111-117. 10.1016/j.jinorgbio.2009.10.002

Full text not available from this repository.

Abstract

A novel ruthenium(II) compound, trans–cis–cis–[Ru(II)Cl2(DMSO)2(2-amino-5-methyl-thiazole)2], (I), PMRu52 hereafter, that may be obtained from the previously described (cis and trans)-[Ru(II)Cl2(DMSO)4] complexes, was designed, synthesized and characterised. The single crystal X-ray structure shows a roughly regular octahedral environment for the ruthenium(II) center with the two chloride ligands in trans and the other two pairs of identical ligands in cis. The behaviour of PMRu52 in phosphate buffer, at pH = 7.4, was characterised spectroscopically as well as its interactions with a few representative biomolecules. Tight ruthenium binding to serum albumin was established by joint use of spectroscopic and separation methods. Afterward, the reactions of PMRu52 with the model proteins ubiquitin and cytochrome c were monitored through electrospray ionisation mass spectrometry (ESI-MS) methods: the formation of metallodrug–protein adducts was documented in detail and the fragmentation patterns of PMRu52 were defined. Finally, the ability of PMRu52 to affect the activity of cathepsin B, a well known cysteine protease, was evaluated in vitro and a pronounced enzyme inhibition highlighted, with an IC50 value of 5.5 μM. This latter finding is of particular interest as cathepsin B constitutes an attractive “druggable” target for cancer, rheumatoid arthritis and other important diseases.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Chemistry
Subjects: Q Science > QD Chemistry
Publisher: Elsevier
Date of Acceptance: 1 October 2009
Last Modified: 31 Oct 2022 08:58
URI: https://orca.cardiff.ac.uk/id/eprint/79345

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item